关键词:
脑出血
卒中
定量脑电图
同型半胱氨酸
预后
评价
摘要:
目的探讨入院血清同型半胱氨酸水平与定量脑电图指标对于脑出血患者不良预后的预测价值。方法回顾性连续收集2017年1月至2022年12月在开滦总医院神经内科重症加强治疗病房诊治的出血性卒中患者89例临床资料。根据出院30 d后的改良Rankin评分(modified Rankin scale,mRS)将患者分为两组:预后良好组(mRS≤2分)、预后不良组(mRS 3~6分)。收集患者临床资料、定量脑电图(quantitative electroencephalogram,qEEG)监测16导联各脑区相关脑电指标。出血预后的影响因素分析采用多因素Logistic回归分析。采用受试者特征(receiver operating characteristic,ROC)曲线分析脑电相关指标及入院同型半胱氨酸预测出血性卒中患者出现不良预后的价值。结果(1)脑出血预后不良组年龄大于预后良好组[(66.51±13.64)岁比(60.53±11.69)岁],t=2.15,P=0.034;入院血清同型半胱氨酸水平显著高于预后良好组[17.28(15.52,24.72)mmol/L比14.50(10.28,16.00)mmol/L,Z=4.14,P<0.001]。(2)脑出血预后不良组10-20导联中Fp1-2、F4、C4、P4、F8、T4导联δ脑波功率值高于预后良好组[87.99(41.57,196.69)比50.67(26.64,54.75),Z=2.76,P=0.006];[79.17(40.71,200.00)比45.06(20.22,61.00),Z=2.10,P=0.036];[72.64(34.97,219.78)比34.42(19.81,63.4),Z=2.03,P=0.043];[65.06(33.36,177.45)比28.12(15.88,63.36),Z=2.08,P=0.038];[52.92(25.64,187.91)比23.61(11.67,43.26),Z=2.21,P=0.027];[66.67(32.56,180.76)比36.31(17.2,53.78),Z=2.46,P=0.014];[57.30(25.24,127.04)比29.57(11.91,41.89),Z=2.26,P=0.024].Fp1-2、F3、F4、C3、C4、P3-4、O1、F7-8、T3-4导联θ脑波功率值高于预后良好组[77.45(47.63,138.72)比35.88(20.92,44.81),Z=3.50,P<0.001];[77.05(35.16,120.22)比38.74(19.86,58.09),Z=2.27,P=0.023];[85.24(52.53,147.90)比35.42(14.7,52.59),Z=2.61,P=0.009];[75.81(37.90,124.97)比36.85(17.92,55.43),Z=2.30,P=0.021];[72.00(43.92,123.54)比28.37(14.02,51.9),Z=2.22,P=0.027];[67.08(32.01,104.05)比31.32(17.98,45.28),Z=2.10,P=0.035];[55.33(32.29,94.30)比25.64(11.87,34.01),Z=2.24,P=0.025];[48.84(20.64,96.28)比19.85(9.83,28.58),Z=2.30,P=0.022];[48.46(25.06,81.78)比23.95(8.80,29.16),Z=2.51,P=0.012];[64.46(39.38,112.44)比26.85(15.74,39.58),Z=2.80,P=0.005];[65.68(31.78,102.00)比31.09(15.98,46.96),Z=2.38,P=0.017];[45.26(28.34,73.14)比21.45(10.57,36.59),Z=2.04,P=0.042];[43.50(22.58,78.67)比25.45(11.91,32.26),Z=2.22,P=0.027];Fp1-2、F3-4、C3-4、P4、F7-8、T4、全脑平均导联慢波指数功率值高于预后良好组[6.64(2.98,10.42)比3.65(2.31,4.30),Z=2.65,P=0.01];[6.53(3.96,11.65)比3.53(2.56,4.51),Z=2.30,P=0.022];[7.38(4.62,13.12)比3.83(1.70,4.71),Z=2.38,P=0.017];[5.88(4.02,12.15)比3.18(2.21,4.46),Z=2.29,P=0.022];[6.13(3.83,11.